Drug profile · INN
ruboxistaurin
ARXXANT
ruboxistaurin (ARXXANT) is a protein kinase c beta inhibitor.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ruboxistaurin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
ruboxistaurin (ARXXANT) is a protein kinase c beta inhibitor.
Key facts
INN ruboxistaurin
Brand ARXXANT
Mechanism Protein kinase C beta inhibitor
Target Protein kinase C beta type
Mechanism of action
Protein kinase C beta inhibitor
Primary target: Protein kinase C beta type
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Frequently asked questions
What is ruboxistaurin?
ruboxistaurin (ARXXANT) is a protein kinase c beta inhibitor.
What is the brand name for ruboxistaurin?
ARXXANT is a marketed brand name for ruboxistaurin. Check FDA Drugs@FDA for the current US label holder and prescribing information.